Scientists have discovered cannabizetol (CBGD), a new cannabis compound with "remarkable antioxidant and skin anti-inflammatory" properties. This dimeric cannabinoid, formed when two cannabinoid molecules bind together, shows promise for dermatological applications and adds to the growing knowledge of marijuana's therapeutic potential. The study, published in the Journal of Natural Products, suggests the existence of other unknown methylene-bridged dimers with potential biological activities. This discovery comes as advances in testing equipment are leading to a deeper understanding of the over 100 known cannabinoids.

Scientists Find New Cannabis Compound with Strong Antioxidant and Anti-Inflammatory Skin Benefits

Oct 3, 2025

Source:

Aaron Houston

Marijuana Moment

Scientists have just added another exciting name to the ever-growing list of cannabinoids: cannabizetol, or CBGD. Research recently published in the Journal of Natural Products reveals that this rare dimeric compound—formed when two molecules join together—packs a serious punch as both an antioxidant and a skin-soothing anti-inflammatory. In fact, it outperformed other known similar compounds in testing, showing massive potential for treating skin issues and general inflammation.

This discovery is a huge win for the community because it proves there is still so much untapped magic hidden within the plant beyond just THC and CBD. As testing technology gets more sophisticated, we are finally seeing the full therapeutic picture of this versatile herb. For everyday tokers, this matters because it paves the way for a new generation of cannabis-infused topicals that actually work on a molecular level. It’s a reminder that every time science digs deeper, they find more reasons why this plant belongs in our wellness routines. The more we understand these minor compounds, the better our access to targeted, natural medicine becomes.